NCT01682187 2024-11-07A Dose-Escalation Study in Participants With Recurrent Malignant GliomaEli Lilly and CompanyPhase 1 Completed66 enrolled
NCT01220271 2017-02-16A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant GliomaEli Lilly and CompanyPhase 1/2 Completed75 enrolled